FDA Adverse Event Injury Summary report: N

TAPERLOC MICROP FMRL 5.0MM

MDR report key: 8119954 · Received November 30, 2018

Report

Report Number
0001825034-2018-10985
Event Type
Injury
Date Received
November 30, 2018
Date of Event
June 29, 2015
Report Date
November 30, 2018
Manufacturer
ZIMMER BIOMET, INC.
Product Code
JDI
PMA / PMN Number
K050441
Removal / Correction Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ZIMMER BIOMET COMPLAINT NUMBER (B)(4). CONCOMITANT MEDICAL PRODUCTS: M2A 38MM MOD; P/N: 11-173661, L/N: 717020; M2A 38MM MOD; P/N: 11-173661, L/N: 040260; TAPERLOC MICROP FMRL; P/N: 14-103200, L/N: 746180; TAPERLOC POR FMRL 5.0X130; P/N: 103200, L/N: 080530; M2A-MAGNUM PF CUP 44ODX38ID; P/N: US157844, L/N: 511670; M2A-MAGNUM PF CUP 44ODX38ID; P/N: US157844, L/N: 857110. COMPLAINT SAMPLE WAS EVALUATED AND THE REPORTED EVENT WAS CONFIRMED. A PICTURE OF THE EXPLANTED HEAD FROM THE RIGHT HIP, WAS PROVIDED. A DAMAGE MARK WAS FOUND ON THE BOTTOM OF THE HEAD. DHR WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. ROOT CAUSE WAS UNABLE TO BE DETERMINED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001825034 - 2015 - 02994 - 4, 0001825034 - 2015 - 04786 - 2, 0001825034 - 2018 - 10985.

Description of Event or Problem · 1

IT WAS REPORTED THAT PATIENT UNDERWENT AN INITIAL BILATERAL HIP ARTHROPLASTY 9 YEARS POST-IMPLANTATION. SUBSEQUENTLY, THE PATIENT WAS REVISED 3 YEARS AGO DUE TO ELEVATED METAL ION, PAIN, INFLAMMATION, AND LIMITED RANGE OF MOTION LEVELS. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
960647 TAPERLOC MICROP FMRL 5.0MM PROSTHESIS, HIP JDI ZIMMER BIOMET, INC. N/A 746180

Patients

Seq Age Sex Outcome Treatment
1 47 YR Hospitalization| R